Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs
Bullboard Posts
User Avatar Image
(0)
•••
Comment by princeofcuton Aug 05, 2015 4:19pm
84 Views
Post# 23992053

RE:RE:RE:Irked

RE:RE:RE:Irked
snippy, thanks for the laugh, i take it from your posting history you are the classic rube likely headed to bagholder status, you are exactly the fool that pikupstixs appeals to.. so gotta laugh here you are in april 2014 pleading for pikupstix pump to come true: << Hopefully Jd's prediction that something significant happens in 2-3 weeks materializes.>> in April 18, 2014 the price of BTI was $1.08...pikuptixs pumps idiocy like $25 price targets to keep rube's like you fully invested...as an investor and as BTI price then and now is the same i conclude whatever pikupstix was pumping never came true... pikupstix is a pro employed by BTI as copy writer (i believe) he is entertainment no more and no less...PS how are those dreamed of "extraordinary share price increases" working out for you...but snippy you do entertain me and i do deserve it..PS if i come back in april 2015 will BTI price be closer to $1.00 or the pikupstix pumpprice of $25, i betcha closer to $1.00 and if you are lucky over $2.00
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities